LB Bacharier, A Boner, KH Carlsen, PA … - Allergy, 2008 - critcaremed.com Asthma is the leading chronic disease among children in most industrialized
countries. However, the evidence base on specific aspects of pediatric asthma,
including therapeutic strategies, is limited and no recent international ... Cited by 81 - Related articles - Cached - BL Direct - All 21 versions
- ►toronto.edu [PDF] A Papi, GW Canonica, P Maestrelli, P Paggiaro, … - The New England journal of medicine, 2007 - nejm.highwire.org From Università di Ferrara, Ferrara (AP); Università di Genova, Genoa (GWC);
Università di Padova, Padua (PM); Uni- versità di Pisa, Pisa (PP); Università
di Parma (DO) and Chiesi Farmaceutici (GN) — both in Parma; Università ... Cited by 71 - Related articles - BL Direct - All 13 versions
- ►annals.org SE Weinberger, LG Smith, VU Collier… - Annals of internal medicine, 2006 - Am Coll Physicians A more recent version of this article appeared on June 20, 2006. ...
Background: Long-acting ß-agonists may increase the risk for fatal and nonfatal
asthma exacerbations. ... Purpose: To assess the risk for severe, life- ... Cited by 64 - Related articles - BL Direct - All 6 versions
PJ Barnes - European Respiratory Journal, 2007 - ersj.org.uk Clinical trials have recently demonstrated that using a budesonide/formoterol
combination inhaler as regular maintenance treatment twice daily but also as a
rescue therapy for breakthrough symptoms can provide more effective control ... Cited by 43 - Related articles - BL Direct - All 7 versions
ER Bleecker, DS Postma, RM Lawrance, DA … - The Lancet, 2008 - Elsevier Asthmatics were stratified by ADRB2 genotype in two studies to assess the
effects of inhaled corticosteroids plus longacting β 2 -agonists on asthma
exacerbations. In study 1 (double-blind), 2250 asthmatics were randomly ... Cited by 39 - Related articles - All 20 versions
- ►annals.org [PDF] P Ernst, A McIvor, FM Ducharme, LP Boulet, … - Annals of internal medicine, 2006 - Am Coll Physicians Long-acting -agonists are a pillar of therapy for many patients with asthma
because they are the preferred add-on therapy to inhaled corticosteroids.
However, a recent meta-analysis docu- mented a substantial increase in ... Cited by 21 - Related articles - BL Direct - All 4 versions
RA Stockley, PJ Whitehead, MK Williams - Respir Res, 2006 - biomedcentral.com Address: 1Queen Elizabeth Hospital, Birmingham, UK and 2GlaxoSmithKline,
Greenford Road, Greenford, Middlesex UB6 OHE, UK Email: Robert A Stockley* -
rastockley@bham.ac.uk; Philip J Whitehead - philip.whitehead@gsk.com; ... Cited by 19 - Related articles - View as HTML - All 12 versions
- ►respireyviva.com [PDF] JM FitzGerald, PG Gibson - British Medical Journal, 2006 - thorax.bmj.com Asthma exacerbations are common. They account for a significant morbidity and
contribute a disproportionate amount to the cost of asthma management. The
optimal strategies for the prevention of asthma exacerbations include the ... Cited by 18 - Related articles - BL Direct - All 9 versions
